Retour
Fourchette du Jour
14,59 €
15,48 €
Fourchette 52 Semaines
8,18 €
22,50 €
Volume
838 461
Moyenne 50J / 200J
16,70 €
/
13,53 €
Clôture Précédente
14,43 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -4,8 | 0,4 |
| P/B | 2,4 | 2,9 |
| ROE % | -49,6 | 3,8 |
| Net Margin % | -314,9 | 3,9 |
| Rev Growth 5Y % | 29,6 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
31,22 €
+112.5%
Low: 28,00 €
High: 36,00 €
BPA Prévisionnel
-3,13 €
CA Est.
58 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-0,35 €
-0,65 € – -0,14 €
|
490 M | 4 |
| FY2029 |
-1,92 €
-3,52 € – -0,76 €
|
240 M | 4 |
| FY2028 |
-2,51 €
-3,48 € – -1,31 €
|
110 M | 10 |
Points Clés
Revenue grew 29,62% annually over 5 years — strong growth
Debt/Equity of 0,10 — conservative balance sheet
Negative free cash flow of -263,47M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 24,33%
Croissance
Revenue Growth (5Y)
29,62%
Revenue (1Y)53,95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-49,63%
ROIC-36,04%
Net Margin-314,90%
Op. Margin-340,16%
Sécurité
Debt / Equity
0,10
Current Ratio7,02
Interest Coverage0,00
Valorisation
P/E Ratio
-4,81
P/B Ratio2,36
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 53,95% | Revenue Growth (3Y) | 4,44% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 29,62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 83,98M | Net Income (TTM) | -264,46M |
| ROE | -49,63% | ROA | -38,43% |
| Gross Margin | 77,55% | Operating Margin | -340,16% |
| Net Margin | -314,90% | Free Cash Flow (TTM) | -263,47M |
| ROIC | -36,04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 7,02 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,81 | P/B Ratio | 2,36 |
| P/S Ratio | 15,16 | PEG Ratio | -0,94 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,27B | Enterprise Value | 1,08B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 83,98M | 54,55M | 76,99M | 38,63M | 29,75M |
| Net Income | -264,46M | -193,57M | -143,95M | -180,36M | -117,19M |
| EPS (Diluted) | -3,05 | -2,88 | -2,65 | -3,71 | -2,73 |
| Gross Profit | 65,12M | -167,08M | -112,16M | -145,87M | -86,68M |
| Operating Income | -285,67M | -213,03M | -155,06M | -183,87M | -117,89M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 688,14M | 669,34M | 355,60M | 416,76M | 476,77M |
| Total Liabilities | 149,39M | 142,35M | 155,11M | 113,06M | 134,47M |
| Shareholders' Equity | 538,75M | 526,99M | 200,49M | 303,70M | 342,30M |
| Total Debt | 55,73M | 28,30M | 30,61M | 11,96M | 13,04M |
| Cash & Equivalents | 246,96M | 110,00M | 54,63M | 64,47M | 80,51M |
| Current Assets | 606,82M | 619,39M | 295,50M | 318,45M | 311,12M |
| Current Liabilities | 86,47M | 95,85M | 86,96M | 70,66M | 66,26M |